ID   VGFR2_RAT               Reviewed;        1343 AA.
AC   O08775;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   02-OCT-2024, entry version 190.
DE   RecName: Full=Vascular endothelial growth factor receptor 2 {ECO:0000305};
DE            Short=VEGFR-2;
DE            EC=2.7.10.1 {ECO:0000250|UniProtKB:P35968};
DE   AltName: Full=Fetal liver kinase 1;
DE            Short=FLK-1;
DE   AltName: Full=Protein-tyrosine kinase receptor flk-1;
DE   AltName: CD_antigen=CD309;
DE   Flags: Precursor;
GN   Name=Kdr {ECO:0000312|RGD:2965}; Synonyms=Flk1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RA   Wen Y., Edelman J.L., De Vries G.W., Sachs G.;
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=10878616;
RX   DOI=10.1002/1097-0177(200007)218:3<507::aid-dvdy1012>3.0.co;2-5;
RA   Pepper M.S., Baetens D., Mandriota S.J., Di Sanza C., Oikemus S.,
RA   Lane T.F., Soriano J.V., Montesano R., Iruela-Arispe M.L.;
RT   "Regulation of VEGF and VEGF receptor expression in the rodent mammary
RT   gland during pregnancy, lactation, and involution.";
RL   Dev. Dyn. 218:507-524(2000).
RN   [3]
RP   PROTEIN SEQUENCE OF 1040-1047, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Lubec G., Kang S.U.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-978 AND SER-980, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Tyrosine-protein kinase that acts as a cell-surface receptor
CC       for VEGFA, VEGFC and VEGFD. Plays an essential role in the regulation
CC       of angiogenesis, vascular development, vascular permeability, and
CC       embryonic hematopoiesis. Promotes proliferation, survival, migration
CC       and differentiation of endothelial cells. Promotes reorganization of
CC       the actin cytoskeleton. Isoforms lacking a transmembrane domain may
CC       function as decoy receptors for VEGFA, VEGFC and/or VEGFD. Modulates
CC       FLT1 and FLT4 signaling by forming heterodimers. Binding of vascular
CC       growth factors to isoform 1 leads to the activation of several
CC       signaling cascades. Activation of PLCG1 leads to the production of the
CC       cellular signaling molecules diacylglycerol and inositol-1,4,5-
CC       trisphosphate and the activation of protein kinase C. Mediates
CC       activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling
CC       pathway, as well as of the AKT1 signaling pathway. Mediates
CC       phosphorylation of PIK3R1, the regulatory subunit of
CC       phosphatidylinositol 3-kinase, reorganization of the actin cytoskeleton
CC       and activation of PTK2/FAK1. Required for VEGFA-mediated induction of
CC       NOS2 and NOS3, leading to the production of the signaling molecule
CC       nitric oxide (NO) by endothelial cells. Phosphorylates PLCG1. Promotes
CC       phosphorylation of FYN, NCK1, NOS3, PIK3R1, PTK2/FAK1 and SRC (By
CC       similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- ACTIVITY REGULATION: Present in an inactive conformation in the absence
CC       of bound ligand. Binding of VEGFA, VEGFC or VEGFD leads to dimerization
CC       and activation by autophosphorylation on tyrosine residues. May be
CC       regulated by hydrogen sulfide (H(2)S) levels via a sensitive
CC       intracellular disulfide bond (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer in the presence of bound dimeric VEGFA, VEGFC or
CC       VEGFD ligands; monomeric in the absence of bound ligands. Can also form
CC       heterodimers with FLT1/VEGFR1 and KDR/VEGFR2. Interacts (tyrosine
CC       phosphorylated) with LFYN, NCK1, PLCG1. Interacts (tyrosine-
CC       phosphorylated active form preferentially) with DAB2IP (via C2 domain
CC       and active form preferentially); the interaction occurs at the late
CC       phase of VEGFA response and inhibits KDR/VEGFR2 activity. Interacts
CC       with SHBSH2D2A/TSAD, GRB2, MYOF, CBL and PDCD6. Interacts (via C-
CC       terminus domain) with ERN1 (via kinase domain); the interaction is
CC       facilitated in a XBP1- and vascular endothelial growth factor (VEGF)-
CC       dependent manner in endothelial cells (By similarity). Interacts (via
CC       juxtamembrane region) with chaperone PDCL3 (via thioredoxin fold
CC       region); the interaction leads to increased KDR/VEGFR2 abundance
CC       through inhibition of its ubiquitination and degradation (By
CC       similarity). Interacts (tyrosine phosphorylated) with CCDC88A/GIV (via
CC       SH2-like region); binding requires autophosphorylation of the
CC       KDR/VEGFR2 C-terminal region (By similarity). Interacts with isoform 2
CC       of BSG (By similarity). Interacts with SLC31A1; this interaction is
CC       induced upon VEGFA stimulation leading to SLC31A1 and KDR subsequent
CC       co-internalization to early endosomes, thereby activating KDR
CC       downstream signaling in endothelial cells (By similarity).
CC       {ECO:0000250|UniProtKB:P35968}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P35968};
CC       Single-pass type I membrane protein {ECO:0000250}. Cytoplasm
CC       {ECO:0000250}. Nucleus {ECO:0000250}. Cytoplasmic vesicle
CC       {ECO:0000250}. Early endosome {ECO:0000250}. Cell junction
CC       {ECO:0000250}. Endoplasmic reticulum {ECO:0000250|UniProtKB:P35968}.
CC       Note=Detected on caveolae-enriched lipid rafts at the cell surface. Is
CC       recycled from the plasma membrane to endosomes and back again.
CC       Phosphorylation triggered by VEGFA binding promotes internalization and
CC       subsequent degradation. VEGFA binding triggers internalization and
CC       translocation to the nucleus. Localized with RAP1A at cell-cell
CC       junctions. Colocalizes with ERN1 and XBP1 in the endoplasmic reticulum
CC       in endothelial cells in a vascular endothelial growth factor (VEGF)-
CC       dependent manner (By similarity). {ECO:0000250|UniProtKB:P35968}.
CC   -!- TISSUE SPECIFICITY: Expressed in the post-pubertal mammary glands.
CC       {ECO:0000269|PubMed:10878616}.
CC   -!- DEVELOPMENTAL STAGE: Increases during pregnancy (1.6-fold at 4 days)
CC       and lactation (3.8-fold at 7 days). Decreases in the early phases of
CC       involution (45%, 50% and 34% on days 1, 2, and 3 respectively).
CC       {ECO:0000269|PubMed:10878616}.
CC   -!- DOMAIN: The second and third Ig-like C2-type (immunoglobulin-like)
CC       domains are sufficient for VEGFC binding. {ECO:0000250}.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- PTM: Ubiquitinated. Tyrosine phosphorylation of the receptor promotes
CC       its poly-ubiquitination, leading to its degradation via the proteasome
CC       or lysosomal proteases (By similarity). {ECO:0000250}.
CC   -!- PTM: Autophosphorylated on tyrosine residues upon ligand binding.
CC       Autophosphorylation occurs in trans, i.e. one subunit of the dimeric
CC       receptor phosphorylates tyrosine residues on the other subunit.
CC       Phosphorylation at Tyr-947 is important for interaction with
CC       SH2D2A/TSAD and VEGFA-mediated reorganization of the actin
CC       cytoskeleton. Phosphorylation at Tyr-1171 is important for interaction
CC       with PLCG1 and SHB. Phosphorylation at Tyr-1210 is important for
CC       interaction with NCK1 and FYN. Dephosphorylated by PTPRB.
CC       Dephosphorylated by PTPRJ at Tyr-797, Tyr-947, Tyr-992, Tyr-1050, Tyr-
CC       1055, Tyr-1171 and Tyr-1210 (By similarity).
CC       {ECO:0000250|UniProtKB:P35968}.
CC   -!- PTM: The inhibitory disulfide bond between Cys-1020 and Cys-1041 may
CC       serve as a specific molecular switch for H(2)S-induced modification
CC       that regulates KDR/VEGFR2 function. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. CSF-1/PDGF receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U93306; AAB97508.1; -; mRNA.
DR   EMBL; U93307; AAB97509.1; -; mRNA.
DR   RefSeq; NP_037194.1; NM_013062.1.
DR   AlphaFoldDB; O08775; -.
DR   SMR; O08775; -.
DR   IntAct; O08775; 1.
DR   MINT; O08775; -.
DR   STRING; 10116.ENSRNOP00000066886; -.
DR   BindingDB; O08775; -.
DR   GlyCosmos; O08775; 16 sites, No reported glycans.
DR   GlyGen; O08775; 16 sites.
DR   iPTMnet; O08775; -.
DR   PhosphoSitePlus; O08775; -.
DR   jPOST; O08775; -.
DR   PaxDb; 10116-ENSRNOP00000066886; -.
DR   GeneID; 25589; -.
DR   KEGG; rno:25589; -.
DR   AGR; RGD:2965; -.
DR   CTD; 3791; -.
DR   RGD; 2965; Kdr.
DR   eggNOG; KOG0200; Eukaryota.
DR   InParanoid; O08775; -.
DR   OrthoDB; 1614410at2759; -.
DR   PhylomeDB; O08775; -.
DR   BRENDA; 2.7.10.1; 5301.
DR   Reactome; R-RNO-194306; Neurophilin interactions with VEGF and VEGFR.
DR   Reactome; R-RNO-195399; VEGF binds to VEGFR leading to receptor dimerization.
DR   Reactome; R-RNO-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-RNO-5218921; VEGFR2 mediated cell proliferation.
DR   PRO; PR:O08775; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0030054; C:cell junction; ISS:UniProtKB.
DR   GO; GO:0071944; C:cell periphery; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005769; C:early endosome; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005768; C:endosome; ISO:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0097443; C:sorting endosome; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0045296; F:cadherin binding; ISO:RGD.
DR   GO; GO:0015026; F:coreceptor activity; ISO:RGD.
DR   GO; GO:0019838; F:growth factor binding; IMP:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0005178; F:integrin binding; ISO:RGD.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; ISO:RGD.
DR   GO; GO:0038085; F:vascular endothelial growth factor binding; ISO:RGD.
DR   GO; GO:0005021; F:vascular endothelial growth factor receptor activity; IMP:RGD.
DR   GO; GO:0001525; P:angiogenesis; IBA:GO_Central.
DR   GO; GO:0060837; P:blood vessel endothelial cell differentiation; ISO:RGD.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; ISO:RGD.
DR   GO; GO:0048754; P:branching morphogenesis of an epithelial tube; ISO:RGD.
DR   GO; GO:0055074; P:calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0045165; P:cell fate commitment; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; ISO:RGD.
DR   GO; GO:0002042; P:cell migration involved in sprouting angiogenesis; ISO:RGD.
DR   GO; GO:1904881; P:cellular response to hydrogen sulfide; ISO:RGD.
DR   GO; GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0035162; P:embryonic hemopoiesis; ISS:UniProtKB.
DR   GO; GO:0003157; P:endocardium development; ISO:RGD.
DR   GO; GO:0003416; P:endochondral bone growth; IMP:RGD.
DR   GO; GO:0045446; P:endothelial cell differentiation; ISO:RGD.
DR   GO; GO:0061154; P:endothelial tube morphogenesis; IMP:RGD.
DR   GO; GO:0003158; P:endothelium development; ISS:UniProtKB.
DR   GO; GO:0002070; P:epithelial cell maturation; ISO:RGD.
DR   GO; GO:0050673; P:epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0030097; P:hemopoiesis; ISO:RGD.
DR   GO; GO:0048286; P:lung alveolus development; ISO:RGD.
DR   GO; GO:0030324; P:lung development; ISO:RGD.
DR   GO; GO:0001945; P:lymph vessel development; ISO:RGD.
DR   GO; GO:0008584; P:male gonad development; IDA:RGD.
DR   GO; GO:0010463; P:mesenchymal cell proliferation; ISO:RGD.
DR   GO; GO:2000352; P:negative regulation of endothelial cell apoptotic process; ISS:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0003085; P:negative regulation of systemic arterial blood pressure; IGI:RGD.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IMP:RGD.
DR   GO; GO:0001541; P:ovarian follicle development; ISO:RGD.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IDA:RGD.
DR   GO; GO:0043536; P:positive regulation of blood vessel endothelial cell migration; ISO:RGD.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; ISO:RGD.
DR   GO; GO:0050850; P:positive regulation of calcium-mediated signaling; IMP:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:RGD.
DR   GO; GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IMP:RGD.
DR   GO; GO:2001028; P:positive regulation of endothelial cell chemotaxis; ISO:RGD.
DR   GO; GO:0010595; P:positive regulation of endothelial cell migration; ISO:RGD.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:RGD.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0051894; P:positive regulation of focal adhesion assembly; ISO:RGD.
DR   GO; GO:0048170; P:positive regulation of long-term neuronal synaptic plasticity; IMP:RGD.
DR   GO; GO:0016239; P:positive regulation of macroautophagy; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0002053; P:positive regulation of mesenchymal cell proliferation; ISO:RGD.
DR   GO; GO:0051901; P:positive regulation of mitochondrial depolarization; ISO:RGD.
DR   GO; GO:0090141; P:positive regulation of mitochondrial fission; ISO:RGD.
DR   GO; GO:0050769; P:positive regulation of neurogenesis; IEP:RGD.
DR   GO; GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IMP:RGD.
DR   GO; GO:0050927; P:positive regulation of positive chemotaxis; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:2000648; P:positive regulation of stem cell proliferation; ISO:RGD.
DR   GO; GO:0032008; P:positive regulation of TOR signaling; IMP:RGD.
DR   GO; GO:2001214; P:positive regulation of vasculogenesis; ISS:UniProtKB.
DR   GO; GO:0048597; P:post-embryonic camera-type eye morphogenesis; ISO:RGD.
DR   GO; GO:1903010; P:regulation of bone development; ISO:RGD.
DR   GO; GO:0008360; P:regulation of cell shape; ISO:RGD.
DR   GO; GO:1901532; P:regulation of hematopoietic progenitor cell differentiation; ISO:RGD.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IBA:GO_Central.
DR   GO; GO:0048678; P:response to axon injury; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IMP:RGD.
DR   GO; GO:0070482; P:response to oxygen levels; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IMP:RGD.
DR   GO; GO:0071526; P:semaphorin-plexin signaling pathway; ISO:RGD.
DR   GO; GO:0072089; P:stem cell proliferation; ISO:RGD.
DR   GO; GO:0043129; P:surfactant homeostasis; ISO:RGD.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IMP:RGD.
DR   GO; GO:0036324; P:vascular endothelial growth factor receptor-2 signaling pathway; ISS:UniProtKB.
DR   GO; GO:0038084; P:vascular endothelial growth factor signaling pathway; ISO:RGD.
DR   GO; GO:0061042; P:vascular wound healing; ISO:RGD.
DR   GO; GO:0001570; P:vasculogenesis; ISS:UniProtKB.
DR   GO; GO:0042311; P:vasodilation; IGI:RGD.
DR   CDD; cd00096; Ig; 1.
DR   CDD; cd05103; PTKc_VEGFR2; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 7.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013151; Immunoglobulin_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR050122; RTK.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR001824; Tyr_kinase_rcpt_3_CS.
DR   InterPro; IPR041348; VEGFR-2_TMD.
DR   InterPro; IPR009136; VEGFR2_rcpt.
DR   PANTHER; PTHR24416; TYROSINE-PROTEIN KINASE RECEPTOR; 1.
DR   PANTHER; PTHR24416:SF45; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; 1.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF00047; ig; 1.
DR   Pfam; PF13927; Ig_3; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF22971; VEGFR-1-like_5th; 1.
DR   Pfam; PF21339; VEGFR-1-like_Ig-like; 1.
DR   Pfam; PF17988; VEGFR-2_TMD; 1.
DR   Pfam; PF22854; VEGFR1-3_N_Ig-like; 1.
DR   PIRSF; PIRSF000615; TyrPK_CSF1-R; 1.
DR   PRINTS; PR01832; VEGFRECEPTOR.
DR   PRINTS; PR01834; VEGFRECEPTR2.
DR   SMART; SM00409; IG; 7.
DR   SMART; SM00408; IGc2; 5.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 7.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50835; IG_LIKE; 5.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00240; RECEPTOR_TYR_KIN_III; 1.
PE   1: Evidence at protein level;
KW   Angiogenesis; ATP-binding; Cell junction; Cell membrane; Cytoplasm;
KW   Cytoplasmic vesicle; Developmental protein; Differentiation;
KW   Direct protein sequencing; Disulfide bond; Endoplasmic reticulum; Endosome;
KW   Glycoprotein; Immunoglobulin domain; Kinase; Membrane; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Receptor; Reference proteome; Repeat; Signal;
KW   Transferase; Transmembrane; Transmembrane helix; Tyrosine-protein kinase;
KW   Ubl conjugation.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..1343
FT                   /note="Vascular endothelial growth factor receptor 2"
FT                   /id="PRO_0000016773"
FT   TOPO_DOM        20..760
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        761..781
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        782..1343
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          46..109
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          141..207
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          224..320
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          328..414
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          421..540
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          547..654
FT                   /note="Ig-like C2-type 6"
FT   DOMAIN          663..749
FT                   /note="Ig-like C2-type 7"
FT   DOMAIN          830..1158
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1267..1314
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1288..1314
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        1024
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         836..844
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         864
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   SITE            1171
FT                   /note="Interaction with SHB"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         797
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P35968"
FT   MOD_RES         947
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P35968"
FT   MOD_RES         978
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         980
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         992
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P35968"
FT   MOD_RES         1050
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P35968"
FT   MOD_RES         1055
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P35968"
FT   MOD_RES         1171
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P35968"
FT   MOD_RES         1210
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P35968"
FT   MOD_RES         1227
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35918"
FT   MOD_RES         1231
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35918"
FT   MOD_RES         1234
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P35918"
FT   MOD_RES         1301
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P35968"
FT   MOD_RES         1305
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P35968"
FT   MOD_RES         1315
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P35968"
FT   CARBOHYD        46
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        96
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        143
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        158
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        245
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        318
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        374
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        395
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        507
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        576
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        609
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        615
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        627
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        671
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        700
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        717
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        53..103
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        150..200
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        246..307
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        445..526
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        567..638
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        684..733
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        1020..1041
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        1204
FT                   /note="Interchain (with C-189 in SLC31A1)"
FT                   /evidence="ECO:0000250|UniProtKB:P35968"
SQ   SEQUENCE   1343 AA;  150394 MW;  AD7E509EB62D3FF4 CRC64;
     MESRALLAVA LWFCVETRAA SVGLPGDSLH PPKLSTQKDI LTILANTTLQ ITCRGQRDLD
     WLWPNTPRDS EERVLVTECG DSIFCKTLTV PRVVGNDTGA YKCFYRDTDV SSIVYVYVQD
     HRSPFIASVS DEHGIVYITE NKNKTVVIPC RGSISNLNVS LCARYPEKRF VPDGNRISWD
     SEKGFTIPSY MISYAGMVFC EAKINDETYQ SIMYIVLVVG YRIYDVVLSP PHEIELSAGE
     KLVLNCTART ELNVGLDFSW QFPSSKHQHK KIVNRDVKSL PGTVAKMFLS TLTIDSVTKS
     DQGEYTCTAY SGLMTKKNKT FVRVHTKPFI AFGSGMKSLV EATVGSQVRI PVKYLSYPAP
     DIKWYRNGRP IESNYTMIVG DELTIMEVSE RDAGNYTVIL TNPISMEKQS HMVSLVVNVP
     PQIGEKALIS PMDSYQYGTM QTLTCTVYAN PPLHHIQWYW QLEEACSYRP SQTNPYTCKE
     WRHVKDFQGG NKIEVTKNQY ALIEGKNKTV STLVIQAAYV SALYKCEAIN KAGRGERVIS
     FHVIRGPEIT VQPATQPTER ESMSLLCTAD RNTFENLTWY KLGSQATSVH MGESLTPVCK
     NLDALWKLNG TVFSNSTNDI LIVAFQNASL QDQGNYVCSA QDKKTKKRHC LVKQLVILER
     MAPMITGNLE NQTTTIGETI EVVCPTSGNP TPLITWFKDN ETLVEDSGIV LKDGNRNLTI
     RRVRKEDGGL YTCQACNVLG CARAETLFII EGVQEKTNLE VIILVGTAVI AMFFWLLLVI
     LVRTVKRANE GELKTGYLSI VMDPDELPLD ERCERLPYDA SKWEFPRDRL KLGKPLGRGA
     FGQVIEADAF GIDKTATCKT VAVKMLKEGA THSEHRALMS ELKILIHIGH HLNVVNLLGA
     CTKPGGPLMV IVEFCKFGNL STYLRGKRNE FVPYKSKGAR FRSGKDYVGE LSVDLKRRLD
     SITSSQSSAS SGFVEEKSLS DVEEEEASEE LYKDFLTLEH LICYSFQVAK GMEFLASRKC
     IHRDLAARNI LLSEKNVVKI CDFGLARDIY KDPDYVRKGD PRLPLKWMAP ETIFDRIYTI
     QSGVWSFGVL LWEIFSLGAS PYPGVKIDEK FCRRLKEGTR MRAPDYTTPE MYQTMLDCWH
     EDPNQRPAFS ELVEHLGNLL QANAQQDGKD YIVLPMSETL SMEEDSGLSL PTSPVSCMEE
     EEVCDPKFHY DNTAGISHYL QNSKRKSRPV SVKTFEDIPL EEPEVKVIPD DSQTDSGMVL
     ASEELKTLED RNKLSPSFGG MMPSKSRESV ASEGSNQTSG YQSGYHSDDT DTTVYSSDEA
     GLLKLVDVAG HVDSGTTLRS SPV
//
